The CROCO Study: CROhn's Disease COhort Study
The CROCO Study is helping us learn more about Crohn's disease over five years. We're following people who have recently been diagnosed and are receiving the most up-to-date treatments. By regularly checking their disease, we aim to understand how it progresses and how different treatments affect it in the long run. We also want to find early signs that could tell us how severe the disease might become. This will help doctors make better treatment plans and improve the lives of people with Crohn's disease. We'll be using special scans to see changes in the gut and collecting information about their health along the way.
De un vistazo
¿De qué trata este estudio?
The CROCO Study is all about understanding Crohn's disease better. Crohn's disease is a long-term condition that causes inflammation in the digestive system. Because it's different for everyone, doctors and researchers want to learn more about how it changes over time, especially with the newest treatments available today.
This study will follow 600 people who have recently been diagnosed with Crohn's disease over five years. By carefully observing their health, treatments, and how their disease progresses, the study hopes to find out what factors lead to clearer and more accurate predictions about how the disease will affect someone in the future. This kind of information is really important because it helps doctors choose the best treatments and manage the disease more effectively, aiming to improve the quality of life for people with Crohn's.
To do this, the study will collect lots of information, including regular check-ups, blood tests, and special scans called MREs (Magnetic Resonance Enterography) to look at the gut. All this information will help researchers understand how treatments work in the long term, track how the disease changes in the body, and ultimately develop better ways to help people living with Crohn's disease.
Puntos clave
- The study aims to understand how Crohn's disease progresses over 5 years.
- It follows people newly diagnosed with Crohn's on current treatments.
- Participation involves regular visits, blood tests, and MRI scans.
- The goal is to improve future treatments and predict disease severity.
- You continue standard Crohn's care while participating.
¿Quién puede ser elegible?
To join the CROCO Study, you must be an adult aged 18 or over and have been diagnosed with Crohn's disease within the last 12 months. It's important that you understand what the study involves and are happy to give your written consent to take part.
There are some reasons why you might not be able to join. For example, if you are pregnant, have a serious medical condition that means you're unlikely to live for at least two more years, or if you cannot have the regular scans because of another health problem (like kidney issues) or strong claustrophobia. Also, if there's any doubt about your Crohn's diagnosis, you wouldn't be able to participate. Most importantly, you need to be willing to take part and follow the study's requirements.
¿Podría este estudio ser adecuado para ti?
Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.
- ¿Tienes 18 años o más?
- Have you been diagnosed with Crohn's disease within the last 12 months?
- Are you able to understand the study and agree to take part?
- Are you able to have MRI scans safely (e.g., no severe claustrophobia)?
- ¿No estás embarazada?
¿En qué consiste la participación?
If you join the CROCO Study, you will be followed for five years after your Crohn's diagnosis. This means you'll have regular visits where doctors will check your health, collect blood and other samples, and ask you to fill out questionnaires about how the disease affects your daily life. After the first year, you'll have visits every six months.
Crucially, you will have special scans called MREs (Magnetic Resonance Enterography) at 1, 3, and 5 years after your diagnosis. Depending on where your disease is located, you might also have other tests like colonoscopies, endoscopies, or pelvic MRI scans. You will continue to receive the standard treatments that your doctor recommends for your Crohn's disease throughout the study. Any surgeries you have during this time will also be recorded.
Riesgos y beneficios potenciales
Locations (19)
- University Hospital CHU of LiègeCódigo postal verificadoLieja, Bélgica
- American Gastroenterology CenterCódigo postal verificadoStróvolos, Cyprus
- IBD Clinical and Research Clinic, ISCARECódigo postal verificadoPraga, Chequia
- Hvidovre HospitalCódigo postal verificadoHvidovre, Denmark
- Slagelse HospitalCódigo postal verificadoSlagelse, Denmark
- CHU Amiens-Picardie Hôpital SudCódigo postal verificadoAmiens, France
- CHU Estaing Clermont - FerrandCódigo postal verificadoClermont-Ferrand, France
- Claude Huriez Hospital, Lille UniversityCódigo postal verificadoLille, Francia
- Azienda Ospedaliera di PadovaCódigo postal verificadoPadova, Italy
- Mater dei hospitalCódigo postal verificadoMsida, Malta
- Hospital Garcia da OrtaCódigo postal verificadoAlmada, Portugal
- Instituto Portugues de Oncologia de LisboaCódigo postal verificadoLisbon, Portugal
Preguntas comunes
What is the main goal of the CROCO Study?
The main goal is to better understand how Crohn's disease changes over time and how different treatments affect it in the long run.
¿Cuánto tiempo estaré involucrado en el estudio?
You'll be followed for five years after your Crohn's disease diagnosis.
Will I still receive my regular Crohn's medication?
Yes, you will continue to receive the standard care and treatments your doctor recommends for your Crohn's disease.
¿Qué tipo de pruebas tendré?
You'll have regular check-ups, blood tests, and special MRE scans at 1, 3, and 5 years. Other scans might be needed depending on your disease.
¿Puedo abandonar el estudio si cambio de opinión?
Yes, you can withdraw from the study at any time without it affecting your usual medical care.
Cómo obtener más información
Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.
Discusión
Discusión comunitaria
Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.